Treating Chronic Symptoms of Pediatric Acquired Brain Injury - a Feasibility Study
NCT ID: NCT04186182
Last Updated: 2021-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2020-08-01
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A feasibility study with six participating children and families will be conducted in close collaboration with schools and local health care providers. The intervention to be tested (the CICI-intervention) focuses on the child's and family's individually identified target outcome areas to be addressed, with corresponding rehabilitation goals. The intervention aims to enhance everyday functioning in the home and school environment by reducing ABI-related symptoms, and by attaining rehabilitation goals in areas noted as challenging by the participants. In the future RCT-study the efficacy of the CICI-intervention will be measured in terms of goal attainment, community participation, cognitive, behavioral, social, and family functioning.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Child in Context Intervention Study
NCT04798859
Eye-tracking Working Memory Training in Children and Youth With Severe Cerebral Palsy
NCT06918379
Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury
NCT00596765
COgnitive REhabilitation in Pediatric Patients with ABI, from Vegetative State to Functional Recovery
NCT04499092
Cognitive Rehabilitation in Pediatric Acquired Brain Injury
NCT03215342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this feasibility study, six children between 6 and 15 years will be included. The children will have a clinical ABI diagnosis, verified injury related intracranial abnormalities, and be more than one year post injury at inclusion. The child and/or their family must report enduring cognitive, emotional, social or physical challenges related to the brain injury. The intervention will be conducted in collaboration with the children's families, schools and their local care providers. It consists of individualized goal-oriented strategies adapted to the home- and school-setting. Goal attainment scaling will be applied. In addition, psychoeducation will be provided to the family and school/local care providers on topics related to the child's injury. Parent group sessions will be held for discussions and knowledge transfer concerning family challenges after a pABI, such as communication skills and parenting. The intervention will include 7 individualized meetings with the family (2 home visits + 5 videoconferences), 2 parent group sessions and 4 meetings with school and local care providers during a period of 4-5 months.
This feasibility study primarily aims to evaluate adherence to the CICI study protocol, responsiveness of participants and therapists, and the usefulness of the intervention. Furthermore, recruitment procedures, assessment protocol, goal setting and the technical solutions will be evaluated. A questionnaire developed for this project will be used to assess the families' satisfaction with the intervention as well as the acceptability of the intervention to families and therapists, while checklists, logs and qualitative interviews will be used to assess the remaining outcomes. Assessments in the future RCT will be conducted at baseline (T1), at the end of the intervention (T2, 4-5 months after inclusion) and one year after inclusion (T3). In the feasibility study, T1 and T2 will be included, as this is considered sufficient to evaluate feasibility of the study protocol as such.
The primary outcomes of the CICI-intervention in the future RCT-study, will be:
* severity of brain injury symptoms (Health and Behavior Inventory - HBI),
* the child's quality of life (The Pediatric Quality of Life Inventory - Peds-QL), and
* parenting self-efficacy (Tool to Measure Parenting Self-Efficacy - TOPSE/Teens TOPSE).
Secondary outcome measures of the CICI-intervention in the future RCT-study, will be:
* changes in self- and parental perceived severity of the individually defined target outcome areas (measured on a 5-point Likert scale),
* goal attainment scaling in the CICI group (Goal Attainment Scaling - GAS),
* emotional symptoms of the children (Child Behavior Checklist (CBCL), Teacher Report Form (TRF) and Youth Self-report (YSR))
* emotional symptoms of the parents (Patient Health Questionnaire 9 - PHQ-9 and Generalized Anxiety Disorder 7 - GAD-7),
* children's executive functioning in the home and school environment (Behavior Rating Inventory of Executive Function 2 - BRIEF-2),
* participation (The Child and Adolescent Scale of Participation - CASP),
* global outcome after pABI (Glasgow Outcome Scale Extended Pediatric Version - GOS-E Peds),
* parental stress (Parental Stress Scale - PSS)
* family functioning (Family Assessment Device - FAD), and
* unmet healthcare needs of the family (The Family Needs Questionnaire - Pediatric version - FNQ-P).
In addition, the neuropsychological screening battery performed at baseline in the future RCT-study will consist of the following test measures: Similarities, Matrix Reasoning, Coding, Digit Span from the Wechsler Intelligence Scale for Children-V, Inhibition and Comprehension of Instructions from Nepsy-II, the Children's Communication Checklist-2 questionnaire and the Children's Auditory Verbal Learning Test-2.
October 27, 2020: This feasibility study was recruiting and in early stages when the Covid-19 pandemic forced a halt in the study in March 2020. The insecurity of the situation caused us not to register the study as suspended, as we hoped from week to week that we would be able to continue. However, the pandemic resulted in a total halt, and reopening of the entire study in august 2020. The new timeline has been adjusted accordingly in the clinical trials.gov records.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CICI - Feasibility trial study group
The feasibility of the entire CICI-protocol will be evaluated. See details above.
CICI - Feasibility trial study group
The intervention will include 7 individualized meetings with the family (2 home visits + 5 videoconferences), 2 parent group sessions and 4 meetings with school and local care providers, delivered over a 4-5 month period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CICI - Feasibility trial study group
The intervention will include 7 individualized meetings with the family (2 home visits + 5 videoconferences), 2 parent group sessions and 4 meetings with school and local care providers, delivered over a 4-5 month period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The above-mentioned children, and/or their parents, report ABI-related cognitive, emotional, or behavioral problems that affect participation in activities with family, friends, school and/or community.
* The children attend school regularly, with or without injury-related adaptations.
* The family is able and willing to actively participate in a goal-oriented approach
Exclusion Criteria
* Patients with brain tumors in active treatment or at great risk of relapse.
* Patients with severe psychiatric illness or children with injuries so severe that they are in institutionalized care.
* Children in custody of the child protection services.
* Parental severe psychiatric illness, drug abuse or indications of a history of or risk of domestic violence.
* The family is not fluent in Norwegian
6 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Research Council of Norway
OTHER
Oslo University Hospital
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
Monash University
OTHER
The Hospital of Vestfold
OTHER
Sunnaas Rehabilitation Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marianne Løvstad, PhD
Role: PRINCIPAL_INVESTIGATOR
Sunnaas Rehabilitation Hospital, University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sunnaas rehabilitation hospital
Nesoddtangen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Svendsen EJ, Killi EM, Rohrer-Baumgartner N, Holthe IL, Sandhaug M, Borgen IMH, Wade SL, Hauger SL, Lovstad M, Bragstad LK. Children's, parents', and teachers' experiences of the feasibility of a telerehabilitation intervention for children with acquired brain injury in the chronic phase - a qualitative study of acceptability and participation in the Child In Context Intervention (CICI). BMC Health Serv Res. 2023 Jun 8;23(1):603. doi: 10.1186/s12913-023-09589-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SunnaasRH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.